ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease.
Antoniou, Katerina M ; Distler, Oliver ; Gheorghiu, Ana-Maria ; Moor, Catharina C ; Vikse, Jens ; Bizymi, Nikoleta ; Galetti, Ilaria ; Brown, Graham ; Bargagli, Elena ; Allanore, Yannick ... show 10 more
Antoniou, Katerina M
Distler, Oliver
Gheorghiu, Ana-Maria
Moor, Catharina C
Vikse, Jens
Bizymi, Nikoleta
Galetti, Ilaria
Brown, Graham
Bargagli, Elena
Allanore, Yannick
Affiliation
University of Crete; University Hospital Zurich; University of Zurich; Cantacuzino Hospital; Carol Davila University; Erasmus Medical Centre; University Medical Centre Rotterdam; University of Bergen; Stavanger University Hospital; PARE/EULAR; ELF/EU-IPFF; University of Siena; Université Paris Cité; Assistance Publique – Hopitaux de Paris; Royal Prince Alfred Hospital; University of Sydney; Hospices Civils de Lyon; Claude Bernard University Lyon 1; University of Birmingham; University Hospitals Birmingham NHS Foundation Trust; St Vincent's University Hospital; University College Dublin; Cedars-Sinai Medical Center; Mainz University Medical Center; Marienhaus Clinic Mainz; Karolinska Institutet; Karolinska University; DIMEC-Bologna University; University Morgagni Hospital; Bern University Hospital; University of Bern; Royal Brompton and Harefield NHS Foundation Trust; Justus-Liebig-University Giessen; University of Chicago; University of Parma; Medical University of Vienna; Bayero University Kano; Aminu-Kano Teaching Hospital; Medical Center - University of Freiburg; University of Freiburg; Oslo University Hospital
Other Contributors
Publication date
2025-09-04
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Background: Interstitial lung disease (ILD) is a frequent manifestation of connective tissue diseases (CTDs) and is associated with high morbidity and mortality. Clinical practice guidelines to standardise screening, diagnosis, treatment and follow-up for CTD-ILD are of high importance for optimised patient care.
Methods: A European Respiratory Society and European Alliance of Associations for Rheumatology task force committee, composed of pulmonologists, rheumatologists, pathologists, radiologists, methodologists and patient representatives, developed recommendations based on PICO (Patients, Intervention, Comparison, Outcomes) questions with grading of the evidence according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluations) methodology and complementary narrative questions agreed on by both societies. For both PICO and narrative questions, the Evidence to Decision framework was used to formulate the recommendations.
Results: The task force committee concluded with recommendations for 25 PICO and 28 narrative questions, regarding ILD in the context of systemic sclerosis, rheumatoid arthritis (RA), idiopathic inflammatory myopathies, Sjögren disease (SjD), systemic lupus erythematosus (SLE) and mixed connective tissue disease (MCTD). In four narrative questions, regarding screening and assessment of risk for ILD progression in MCTD, SjD and SLE and one PICO question regarding pirfenidone in CTD-ILD other than RA-ILD, the task force had insufficient evidence to support recommendations. Screening, diagnostic, monitoring and treatment algorithms were developed based on the recommendations and usual clinical practice.
Conclusions: We provide practical guidance by evidence-based recommendations to clinicians for each of the CTDs. In many cases there is low certainty or absence of evidence and we encourage further research to fill these gaps.
Citation
Antoniou KM, Distler O, Gheorghiu AM, Moor CC, Vikse J, Bizymi N, Galetti I, Brown G, Bargagli E, Allanore Y, Corte TJ, Dieudé P, Cottin V, Fisher BA, Fabre A, Giles JT, Kreuter M, Lundberg IE, Poletti V, Maurer B, Renzoni EA, Müller-Ladner U, Strek ME, Sverzellati N, Studenic P, Mohammed J, Nagavci B, Stamm T, Tonia T, Crestani B, Hoffmann-Vold AM. ERS/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease. Ann Rheum Dis. 2025 Sep 3:S0003-4967(25)04320-1. doi: 10.1016/j.ard.2025.08.021. Epub ahead of print.
Type
Article
